How new tobacco products may change smoking and long-term health
Modeling the Impact of Novel Tobacco Product use on Smoking and Long-Term Health Outcomes
This project uses national data and computer models to predict how e-cigarettes, cigars, heated tobacco, and other new nicotine products could change smoking habits and future health for people in the U.S.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11168761 on NIH RePORTER |
What this research studies
This work combines large U.S. health surveys, published research, and tobacco-use estimates to build computer simulations of how people start, stop, or switch between cigarettes, cigars, e-cigarettes (ENDS), heated tobacco products, and other novel nicotine products. The team will map out typical use patterns over time and estimate how those patterns shift when new products appear or when rules change. They will then model how those changes in use could affect long-term health outcomes like smoking-related disease and premature death. Results are intended to help regulators understand population-level harms and benefits of different policy choices.
Who could benefit from this research
Good fit: People who currently smoke cigarettes, use e-cigarettes, cigars, heated tobacco, or other nicotine products — including adults and youth represented in U.S. national surveys — are the populations this work focuses on.
Not a fit: People who never use tobacco or who live outside the U.S. or use very rare nicotine products not captured in national data are unlikely to see direct benefits from this modeling.
Why it matters
Potential benefit: If successful, the project could help regulators make rules that reduce smoking-related illness and deaths by showing which actions are likely to improve public health.
How similar studies have performed: Related tobacco simulation models from the Center for the Assessment of Tobacco Regulations have been used to inform policy decisions before, though modeling new products and long-term effects remains complex and uncertain.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Levy, David Theodore — University of Michigan at Ann Arbor
- Study coordinator: Levy, David Theodore
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.